Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers urges shareholders in open letter to support $74 billion Celgene deal amid resistance
Bristol-Myers urges shareholders in open letter to support $74 billion Celgene deal amid resistance
Bristol-Myers urges shareholders in open letter to support $74 billion Celgene deal amid resistance
Submitted by
admin
on March 6, 2019 - 9:53am
Source:
CNBC
News Tags:
Bristol-Myers Squibb
M&A
Celgene
Headline:
Bristol-Myers urges shareholders in open letter to support $74 billion Celgene deal amid resistance
snippet:
Bristol-Myers Squibb urged investors to support its $74 billion purchase of cancer drugmaker Celgene.
Its board of directors are "confident" the drugmakers acquisition is the best path forward.
Do Not Allow Advertisers to Use My Personal information
